Castle Biosciences CEO Derek J. Maetzold trims stake by 14,496 shares worth $512,445.26

Bitget2026/09/23 20:27

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Castle Biosciences CEO Derek J. Maetzold exercised stock options for 8,580 shares at $2.39 on Sept. 21, 2026.
He sold 8,580 shares at a weighted-average $35.33, cutting his direct stake to 21,479 shares.
Separate sales of 3,198 shares, 2,718 shares were reported from trusts tied to Maetzold at $35.33.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Castle Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-063221), on September 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Castle Biosciences CEO Derek J. Maetzold trims stake by 14,496 shares worth $512,445.26

You may also like

Crypto prices